Chong Kun Dang Pharmaceutical competitive analysis

Latest publications and patents of Chong Kun Dang Pharmaceutical New

Explore the latest publications and patents granted to Chong Kun Dang Pharmaceutical, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Chong Kun Dang Pharmaceutical

Feb 7, 2024Injectable Long-Acting Naltrexone Microparticle CompositionsGranted And Under Opposition

Explore Chong Kun Dang Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 7, 2024Injectable Long-Acting Naltrexone Microparticle Compositions1

Latest PTAB cases involving Chong Kun Dang Pharmaceutical

Discover the latest PTAB cases involving Chong Kun Dang Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Chong Kun Dang Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
CHONG KUN DANG PHARMACEUTICAL - 1 - - Non-Active
ALKERMES PHARMA IRELAND6912Balanced